Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ) Latest Company News

Oct 23, 2026, 08:49 UTC
Yuyue Medical reported third-quarter 2026 revenue of 2.042 billion yuan, attributable net profit of 2.8848 billion yuan, and adjusted net profit of 276 million yuan; for the first nine months, it reported revenue of 6.611 billion yuan, attributable net profit of 1.133 billion yuan, and adjusted net profit of 1.037 billion yuan.
Source:
- finance.sina.cn
Oct 8, 2026, 10:45 UTC
Yuyue Medical said it had repurchased 8.7576 million A-shares for a total of RMB 228 million, excluding transaction fees, by September 30, 2026.
Source:
- finance.sina.cn
Sep 28, 2026, 13:51 UTC
Yuyue Medical announced a share buyback plan of up to RMB 400 million for equity incentives or employee stock ownership plans.
Source:
- nbd.com.cn
Sep 17, 2026, 10:24 UTC
Yuyue Medical completed the cancellation of 7.8302 million repurchased shares on September 16, 2026, reducing its total share capital by 0.7811% to 995 million shares with a repurchase amount of 200 million yuan.
Source:
- finance.sina.cn
Sep 15, 2026, 10:46 UTC
Yuyue Medical repurchased 2.5479 million shares for RMB 64.9954 million as of September 15, 2026, bringing cumulative repurchases to 10.3781 million shares, or 1.0352% of total share capital, for RMB 265 million under a plan of up to RMB 400 million at no more than RMB 40 per share.
Source:
- finance.sina.cn
Sep 10, 2026, 09:50 UTC
Yuyue Medical repurchased 588,639 A-shares for the first time on September 10, 2026, representing 0.0587% of total share capital, with a total transaction amount of 14.9986 million yuan, at a highest price of 25.67 yuan/share and a lowest price of 25.38 yuan/share.
Source:
- finance.sina.cn
Sep 8, 2026, 10:51 UTC
Yuwell Medical completed its share buyback, repurchasing 7.8302 million shares at prices between 23.91 and 27 yuan per share, totaling 200 million yuan, and decided to terminate the buyback early as the minimum limit was reached.
Source:
- finance.sina.cn
Sep 1, 2026, 09:50 UTC
Yuwell Medical announced that as of August 31, 2026, it had repurchased 6.731554 million shares for a total of 171 million yuan, as part of its ongoing share buyback program for cancellation.
Source:
- finance.sina.cn
Aug 31, 2026, 11:48 UTC
Yuwell Medical's wholly-owned subsidiary Yuwell (Hong Kong) Holdings Limited announced its intention to subscribe for no more than HKD 100 million of A1 shares in two funds under CFTC Summit Fund SPC, investing in PE-to-IPO stage projects in artificial intelligence and semiconductor chip sectors.
Source:
- finance.sina.cn
- nbd.com.cn

002223.SZ

Yuyue Medical said it had repurchased 8.7576 million A-shares for a total of RMB 228 million, excluding transaction fees, by September 30, 2026.

Yuyue Medical announced a share buyback plan of up to RMB 400 million for equity incentives or employee stock ownership plans.

Yuyue Medical completed the cancellation of 7.8302 million repurchased shares on September 16, 2026, reducing its total share capital by 0.7811% to 995 million shares with a repurchase amount of 200 million yuan.

Yuyue Medical repurchased 2.5479 million shares for RMB 64.9954 million as of September 15, 2026, bringing cumulative repurchases to 10.3781 million shares, or 1.0352% of total share capital, for RMB 265 million under a plan of up to RMB 400 million at no more than RMB 40 per share.

Yuyue Medical repurchased 588,639 A-shares for the first time on September 10, 2026, representing 0.0587% of total share capital, with a total transaction amount of 14.9986 million yuan, at a highest price of 25.67 yuan/share and a lowest price of 25.38 yuan/share.

Yuwell Medical completed its share buyback, repurchasing 7.8302 million shares at prices between 23.91 and 27 yuan per share, totaling 200 million yuan, and decided to terminate the buyback early as the minimum limit was reached.

Yuwell Medical announced that as of August 31, 2026, it had repurchased 6.731554 million shares for a total of 171 million yuan, as part of its ongoing share buyback program for cancellation.

Yuwell Medical's wholly-owned subsidiary Yuwell (Hong Kong) Holdings Limited announced its intention to subscribe for no more than HKD 100 million of A1 shares in two funds under CFTC Summit Fund SPC, investing in PE-to-IPO stage projects in artificial intelligence and semiconductor chip sectors.